Liu Pentao

Title: Innovations in Molecular Diagnosis by Liu Pentao

Introduction

Liu Pentao is an accomplished inventor based in Houston, Texas. He has made significant contributions to the field of molecular diagnostics, particularly in relation to Charcot-Marie-Tooth disease. His innovative work has the potential to enhance the understanding and detection of this hereditary neuropathy.

Latest Patents

Liu Pentao holds a patent for the "Molecular diagnosis of autosomal dominant Charcot-Marie-Tooth disease." This patent describes an isolated CMTIA-REP sequence and DNA probes associated with the sequence. The methods outlined in the patent enable the detection of peripheral neuropathies. Specifically, it includes a method for detecting Charcot-Marie-Tooth disease type 1 by measuring the presence or absence of a DNA duplication in a gene locus linked to the CMTIA-REP sequence. Additionally, it provides a method for detecting Hereditary Neuropathy with Liability to Pressure Palsies by assessing the presence or absence of a DNA deletion in the same gene locus.

Career Highlights

Liu Pentao is affiliated with the Baylor College of Medicine, where he continues to advance his research in molecular diagnostics. His work is pivotal in the ongoing efforts to improve diagnostic techniques for genetic disorders.

Collaborations

Liu has collaborated with notable colleagues, including James R. Lupski and Benjamin B. Roa. These partnerships have further enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Liu Pentao's innovative contributions to molecular diagnostics exemplify the impact of research on understanding genetic diseases. His patent for the diagnosis of Charcot-Marie-Tooth disease represents a significant advancement in the field.